Trekrezan, a synthetic compound sold in Russia as an over-the-counter medicine to raise general resistance to infection, cold, low oxygen and heavy workloads, has never been studied for aging or lifespan. Two small human studies suggest respiratory infections resolve somewhat faster and physical performance holds up better in the cold. Short courses appear well tolerated; the main open safety question is long-term exposure to one of its two components. (Full Review)
| Marker | Target | Why |
|---|---|---|
| White blood cell count with lymphocyte count | 4.5–11.0 ×10⁹/L total; lymphocytes 1.0–4.8 ×10⁹/L | Immune modulation |
| ESR (erythrocyte sedimentation rate) | 0–20 mm/h | Inflammation marker |
| Fasting plasma glucose | 70–99 mg/dL | Safety check: label caution in diabetes |
| Serum creatinine | 0.7–1.3 mg/dL men; 0.6–1.1 mg/dL women | Safety check: renal excretion |
| eGFR (estimated glomerular filtration rate) | Not specified in the ER | Kidney filtration, paired with creatinine |
Cadence: Baseline before a first course; repeat blood count at the end of each 8–14-day course if baseline values were abnormal; daily home glucose during each course for people with diabetes; creatinine every 6–12 months if courses are repeated several times a year